» Articles » PMID: 18329615

Human Immunodeficiency Virus Type 1 Tat Protein Inhibits the SIRT1 Deacetylase and Induces T Cell Hyperactivation

Overview
Publisher Cell Press
Date 2008 Mar 11
PMID 18329615
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

Symptoms of T cell hyperactivation shape the course and outcome of HIV-1 infection, but the mechanism(s) underlying this chronic immune activation are not well understood. We find that the viral transactivator Tat promotes hyperactivation of T cells by blocking the nicotinamide adenine dinucleotide (NAD(+))-dependent deacetylase SIRT1. Tat directly interacts with the deacetylase domain of SIRT1 and blocks the ability of SIRT1 to deacetylate lysine 310 in the p65 subunit of NF-kappaB. Because acetylated p65 is more active as a transcription factor, Tat hyperactivates the expression of NF-kappaB-responsive genes, a function lost in SIRT1-/- cells. These results support a model where the normal function of SIRT1 as a negative regulator of T cell activation is suppressed by Tat during HIV infection. These events likely contribute to the state of immune cell hyperactivation found in HIV-infected individuals.

Citing Articles

Viruses and the Brain-A Relationship Prone to Trouble.

Mielcarska M, Rouse B Viruses. 2025; 17(2).

PMID: 40006958 PMC: 11860391. DOI: 10.3390/v17020203.


HIV-1 Tat Protein and Cigarette Smoke Mediated ADAM17 Upregulation Can Lead to Impaired Mucociliary Clearance.

Panda K, Santiago M, Rahman M, Ghorai S, Black S, Rahman I Cells. 2024; 13(23).

PMID: 39682757 PMC: 11640087. DOI: 10.3390/cells13232009.


Multi-protomics analysis identified host cellular pathways perturbed by tick-borne encephalitis virus infection.

Sui L, Wang W, Guo X, Zhao Y, Tian T, Zhang J Nat Commun. 2024; 15(1):10435.

PMID: 39616195 PMC: 11608235. DOI: 10.1038/s41467-024-54628-w.


Altered Host microRNAomics in HIV Infections: Therapeutic Potentials and Limitations.

Santiago M, Chinnapaiyan S, Panda K, Rahman M, Ghorai S, Rahman I Int J Mol Sci. 2024; 25(16.

PMID: 39201495 PMC: 11354509. DOI: 10.3390/ijms25168809.


Combination antiretroviral therapy prevents SIV- induced aging in the hippocampus and neurodegeneration throughout the brain.

MacLean A, Horn M, Midkiff C, Van Zandt A, Saied A Res Sq. 2024; .

PMID: 39149452 PMC: 11326353. DOI: 10.21203/rs.3.rs-4681317/v1.


References
1.
Dorr A, Kiermer V, Pedal A, Rackwitz H, Henklein P, Schubert U . Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain. EMBO J. 2002; 21(11):2715-23. PMC: 125383. DOI: 10.1093/emboj/21.11.2715. View

2.
Wei P, Garber M, Fang S, Fischer W, Jones K . A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell. 1998; 92(4):451-62. DOI: 10.1016/s0092-8674(00)80939-3. View

3.
Blander G, Guarente L . The Sir2 family of protein deacetylases. Annu Rev Biochem. 2004; 73:417-35. DOI: 10.1146/annurev.biochem.73.011303.073651. View

4.
Baur J, Sinclair D . Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006; 5(6):493-506. DOI: 10.1038/nrd2060. View

5.
Fenard D, Yonemoto W, de Noronha C, Cavrois M, Williams S, Greene W . Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement. J Immunol. 2005; 175(9):6050-7. DOI: 10.4049/jimmunol.175.9.6050. View